Neuspera Medical this week announced its ultra-miniaturized neurostimulator system received FDA clearance. The Neuspera system is a micro-implant that delivers neurostimulation therapy through a wireless platform, including a wearable transmitter and iPad-based clinician programmer. The company designed the system to provide peripheral nerve stimulation (PNS) in an ultra-miniaturized option to allow for a better patient […]
NeuSpera Medical
Neuspera Medical appoints new CEO
Implantable neuromodulation technology developer Neuspera Medical announced today that Steffen Hovard joined the company as CEO. Hovard most recently served as president of Coloplast’s interventional urology arm. He had leadership responsibilities across four business areas within urological devices. At Coloplast, he oversaw 900 employees across 19 countries. According to a news release, Hovard also serves […]
Neuspera Medical raises $26m Series B for injectable neuromod device
Neuspera Medical said today that it raised a $26 million Series B round for the injectable neuromodulation devices it’s developing. Formerly known as Vivonda Medical, San Jose, Calif.-based Neuspera said the round was led by 6 Dimensions Capital, joined by all of its Series A investors, including Action Potential Venture Capital and Windham Venture Partners, and new […]
Neuspera closes $9m funding round
NeuSpera Medical closed an $9 million round of equity financing, according to a new SEC filing from the company. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices. […]
NeuSpera raises $8m for injectable neuromod devices
NeuSpera Medical said yesterday it raised $8 million in a new round of equity financing to support its injectable neuromodulation devices. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other […]
NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves
NeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it gears up to raise a Series A round for its neuromodulation technology. NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, […]